Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/81558| Title: | Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration | Authors: | Meredith, Erik L. Mainolfi, Nello Poor, Stephen Qiu, Yubin Miranda, Karl Powers, James Liu, Donglei Ma, Fupeng Solovay, Catherine Rao, Chang Johnson, Leland Ji, Nan Artman, Gerald Hardegger, Leo Hanks, Shawn Shen, Siyuan Woolfenden, Amber Fassbender, Elizabeth Sivak, Jeremy M. Zhang, Yiqin Long, Debby Cepeda, Rosemarie Liu, Fang Hosagrahara, Vinayak P. Lee, Wendy Tarsa, Peter Anderson, Karen Elliott, Jason Jaffee, Bruce |
Keywords: | pyrimidine derivative capsule endoscope |
Issue Date: | 2015 | Source: | Meredith, E. L., Mainolfi, N., Poor, S., Qiu, Y., Miranda, K., Powers, J., et al. (2015). Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration. Journal of Medicinal Chemistry, 58(23), 9273-9286. | Series/Report no.: | Journal of Medicinal Chemistry | Abstract: | The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an ocular indication provides opportunities for dosing routes beyond intravitreal injection. We employed a high–throughput in vivo screening strategy with rodent models of choroidal neovascularization and iterative compound design to identify VEGFR-2 inhibitors with potential to benefit wet AMD patients. These compounds demonstrate preferential ocular tissue distribution and efficacy after oral administration while minimizing systemic exposure. | URI: | https://hdl.handle.net/10356/81558 http://hdl.handle.net/10220/39573 |
ISSN: | 0022-2623 | DOI: | 10.1021/acs.jmedchem.5b01227 | Rights: | © 2015 American Chemical Society. This paper was published in Journal of Medicinal Chemistry and is made available as an electronic reprint (preprint) with permission of American Chemical Society. The published version is available at: [http://dx.doi.org/10.1021/acs.jmedchem.5b01227]. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law. | Fulltext Permission: | open | Fulltext Availability: | With Fulltext |
| Appears in Collections: | SBS Journal Articles |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.pdf | 1.28 MB | Adobe PDF |  View/Open |
SCOPUSTM
Citations
10
17
Updated on Jul 21, 2020
PublonsTM
Citations
10
18
Updated on Mar 3, 2021
Page view(s)
132
Updated on Apr 11, 2021
Download(s) 20
245
Updated on Apr 11, 2021
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.